Results 101 to 110 of about 4,764 (176)

Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection Fraction. [PDF]

J Clin Med
Weidner K, Behnes M, Reinhardt M, Abel N, Schmitt A, Lau F, Abumayyaleh M, Hetjens S, Steffen HJ, Akin I, Schupp T.   +10 more
europepmc   +1 more source

Predicting Sudden Cardiac Death in Heart Failure with Mildly Reduced/Preserved Left Ventricular Ejection Fraction: A Clinical Review. [PDF]

J Clin Med
Feola M, Landra F, Greco CA, Lorusso R, Ruocco G.   +4 more
europepmc   +1 more source

Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration. [PDF]

Drugs Drug Candidates
Al-Horani RA, Goyal N.
europepmc   +1 more source

LightGBM-Based Classification of Heart Failure Phenotypes Using Morpho-Energy Features from High-Resolution ECG. [PDF]

Sensors (Basel)
Gader MA, Karmani S, Djemal R, Sakuyama CV.   +3 more
europepmc   +1 more source

A non-linear pattern of exercise capacity in heart failure across ejection fraction categories. [PDF]

Sci Rep
Kurpaska M, Krzesiński P, Świerkowska M, Piotrowicz K.   +3 more
europepmc   +1 more source

Letter to the Editor on: worse long-term outcomes in new-onset HFpEF vs HFrEF and HFmrEF: findings from the Stockholm PREFERS study. [PDF]

ESC Heart Fail
Bellicini MG.
europepmc   +1 more source

Lactate dehydrogenase-to-albumin ratio and adverse outcomes in patients with HFrEF and HFmrEF. [PDF]

Front Cardiovasc Med
Zhang Y, Ma Q, Hu N, Men B, Zhang J, Shi X, Zhang J.   +6 more
europepmc   +1 more source

Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India. [PDF]

Cureus
Pandey BP, Ray S, Kumar S, Guha S, Desai BN, Shah MK, Kudva S, Chopra VK, Agarwal R, Rastogi V, Ponde CK, Sharma RK, Pawar D, Chavan G, Kolapkar V.   +14 more
europepmc   +1 more source

Heart failure subgroups: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation [PDF]

European Heart Journal, 2018
openaire   +3 more sources

Letter to Dr Maria Giulia Bellicini, MD, Brescia, in response to her letter to the editor of our published paper in ESC Heart Failure (online); Worse long-term outcomes in new-onset HFpEF vs HFrEF and HFmrEF: findings from the Stockholm PREFERS study. [PDF]

ESC Heart Fail
Persson H, Winderud A, Hage C, Corovic Cabrera C, Löfström U, Lyngå P, Arslan T, Knudsen Malmqvist K, Eriksson MJ, Persson B, Wallén H, Ekström M, Linde C.   +12 more
europepmc   +1 more source